NCT05676450View on ClinicalTrials.gov

Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas

NARecruitingINTERVENTIONAL
Enrollment

517

Participants

Timeline

Start Date

February 23, 2023

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Lymphoma
Interventions
DIAGNOSTIC_TEST

cell-free DNA

Given by IV (vein)

Trial Locations (2)

77030

RECRUITING

MD Anderson Cancer Center, Houston

78229

RECRUITING

Cancer Therapy and Research Center at The UT Health Science Center at San Antonio, San Antonio

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER